Bioventus Inc.
NASDAQ:BVS
11.84 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2016 Q1 | 2015 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 138.964 | 151.217 | 129.457 | 135.423 | 120.794 | 137.069 | 119.059 | 125.834 | 128.662 | 140.331 | 117.29 | 130.414 | 108.89 | 109.816 | 81.778 | 98.591 | 85.908 | 58.017 | 78.645 | 97.554 | 82.241 | 80.173 | 80.173 | 65.402 | 53.362 |
| Cost of Revenue
| 45.413 | 49.642 | 42.832 | 51.224 | 41.944 | 47.946 | 45.14 | 51.645 | 44.127 | 43.677 | 41.588 | 42.646 | 29.821 | 33.503 | 22.222 | 25.121 | 23.444 | 17.668 | 21.409 | 24.125 | 21.684 | 22.563 | 22.563 | 19.235 | 16.807 |
| Gross Profit
| 93.551 | 101.575 | 86.625 | 84.199 | 78.85 | 89.123 | 73.919 | 74.189 | 84.535 | 96.654 | 75.702 | 87.768 | 79.069 | 76.313 | 59.556 | 73.47 | 62.464 | 40.349 | 57.236 | 73.429 | 60.557 | 57.61 | 57.61 | 46.167 | 36.555 |
| Gross Profit Ratio
| 0.673 | 0.672 | 0.669 | 0.622 | 0.653 | 0.65 | 0.621 | 0.59 | 0.657 | 0.689 | 0.645 | 0.673 | 0.726 | 0.695 | 0.728 | 0.745 | 0.727 | 0.695 | 0.728 | 0.753 | 0.736 | 0.719 | 0.719 | 0.706 | 0.685 |
| Reseach & Development Expenses
| 3.808 | 3.988 | 2.597 | 3.262 | 3.015 | 3.398 | 3.771 | 6.807 | 4.614 | 6.366 | 6.928 | 7.103 | 6.153 | 4.836 | 0.947 | 2.891 | 3.569 | 2.596 | 2.146 | 3.144 | 2.849 | 2.531 | 2.531 | 3.718 | 2.966 |
| General & Administrative Expenses
| 0 | 0 | 0 | 72.831 | 0 | 0 | 0 | 72.465 | 0 | 0 | 0 | 77.008 | 0 | 0 | 0 | 59.205 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 3.853 | 0 | 0 | 0 | 5.203 | 0 | 0 | 0 | 3.873 | 0 | 0 | 0 | 2.769 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 81.09 | 91.94 | 77.843 | 76.684 | 69.82 | 74.844 | 80.858 | 77.668 | 78.955 | 89.62 | 86.124 | 80.881 | 69.636 | 69.05 | 34.686 | 61.974 | 50.295 | 40.533 | 40.276 | 54.454 | 45.118 | 49.452 | 49.452 | 40.184 | 37.27 |
| Other Expenses
| 0 | -0.159 | -0.063 | 0.709 | -0.494 | -0.513 | 2.129 | 7.761 | 0 | 2.696 | 3.254 | -0.508 | -0.757 | -1.645 | -0.419 | -0.111 | 3.285 | 1.337 | -0.083 | 0.146 | 0 | 0 | 0 | 2.83 | 2.571 |
| Operating Expenses
| 84.898 | 95.928 | 80.44 | 79.946 | 75.152 | 80.536 | 86.758 | 92.236 | 211.489 | 98.682 | 96.306 | 90.692 | 77.667 | 75.738 | 37.558 | 66.999 | 55.531 | 44.942 | 44.247 | 59.691 | 50.028 | 54.165 | 54.165 | 46.732 | 42.807 |
| Operating Income
| 4.074 | 5.647 | 6.185 | 4.253 | 2.418 | 6.75 | 66.38 | -18.047 | -1.289 | -0.748 | -20.604 | -3.15 | -1.047 | -5.74 | 21.998 | 5.908 | 6.933 | -4.593 | 12.989 | 13.703 | 10.605 | 3.713 | 3.713 | -2.038 | -16.299 |
| Operating Income Ratio
| 0.029 | 0.037 | 0.048 | 0.031 | 0.02 | 0.049 | 0.558 | -0.143 | -0.01 | -0.005 | -0.176 | -0.024 | -0.01 | -0.052 | 0.269 | 0.06 | 0.081 | -0.079 | 0.165 | 0.14 | 0.129 | 0.046 | 0.046 | -0.031 | -0.305 |
| Total Other Income Expenses Net
| -8.906 | -10.083 | -10.402 | -9.571 | -10.609 | -11.1 | -8.106 | -24.279 | -129.269 | -3.462 | 1.512 | -1.468 | -2.104 | -3.326 | 2.457 | -2.767 | 1.405 | -1.497 | -2.464 | -7.498 | -4.616 | -4.695 | -4.695 | -3.408 | -4.35 |
| Income Before Tax
| -4.832 | -39.451 | -5.075 | -8.406 | -8.191 | -4.35 | -100.164 | -49.714 | -130.558 | -6.77 | -19.938 | -4.618 | -3.151 | -9.066 | 24.455 | 3.141 | 8.338 | -6.09 | 10.525 | 6.205 | 5.978 | -1.247 | -1.247 | -5.446 | -20.649 |
| Income Before Tax Ratio
| -0.035 | -0.261 | -0.039 | -0.062 | -0.068 | -0.032 | -0.841 | -0.395 | -1.015 | -0.048 | -0.17 | -0.035 | -0.029 | -0.083 | 0.299 | 0.032 | 0.097 | -0.105 | 0.134 | 0.064 | 0.073 | -0.016 | -0.016 | -0.083 | -0.387 |
| Income Tax Expense
| 0.589 | -7.339 | 0.907 | -0.75 | 0.6 | 0.381 | -0.146 | -4.841 | 29.523 | 1.244 | -5.132 | -2.725 | -0.882 | 1.714 | -0.073 | 0.89 | 0.373 | -0.11 | 0.039 | 0.892 | 0.369 | 0.158 | 0.158 | 0.603 | 0.369 |
| Net Income
| -4.824 | -23.992 | -4.57 | -6.096 | -7.303 | -3.681 | -100.018 | -44.873 | -72.833 | -8.014 | -14.806 | -0.364 | -1.071 | -4.126 | 24.936 | 2.776 | 8.457 | -5.766 | 10.944 | 5.637 | 4.155 | -2.873 | -2.873 | -6.049 | -21.018 |
| Net Income Ratio
| -0.035 | -0.159 | -0.035 | -0.045 | -0.06 | -0.027 | -0.84 | -0.357 | -0.566 | -0.057 | -0.126 | -0.003 | -0.01 | -0.038 | 0.305 | 0.028 | 0.098 | -0.099 | 0.139 | 0.058 | 0.051 | -0.036 | -0.036 | -0.092 | -0.394 |
| EPS
| -0.074 | -0.37 | -0.072 | -0.097 | -0.12 | -0.059 | -1.61 | -0.72 | -1.18 | -0.13 | -0.24 | -0.007 | -0.026 | -0.099 | 0.6 | 0.074 | 0.15 | -0.1 | 0.2 | 0.1 | 0.85 | -0.59 | -0.59 | -0.11 | -0.38 |
| EPS Diluted
| -0.074 | -0.37 | -0.072 | -0.097 | -0.12 | -0.059 | -1.61 | -0.72 | -1.18 | -0.13 | -0.24 | -0.007 | -0.026 | -0.099 | 0.6 | 0.074 | 0.15 | -0.1 | 0.2 | 0.1 | 0.85 | -0.59 | -0.59 | -0.11 | -0.38 |
| EBITDA
| 50.71 | -16.437 | 17.407 | 14.339 | 17.525 | 23.187 | -73.997 | -27.58 | -113.361 | 8.192 | -8.125 | 8.766 | 6.718 | 8.054 | 29.182 | 11.6 | 14.209 | 2.655 | 20.254 | 21.193 | 17.959 | 8.287 | 8.287 | 6.898 | -8.857 |
| EBITDA Ratio
| 0.365 | 0.124 | 0.139 | 0.123 | 0.141 | 0.165 | 0.696 | -0.034 | 0.096 | 0.083 | -0.062 | 0.063 | 0.084 | 0.131 | 0.357 | 0.086 | 0.204 | 0.046 | 0.258 | 0.218 | 0.218 | 0.103 | 0.103 | 0.131 | 0.04 |